Diagnosis and Treatment of Chronic Hoarseness, Cough, and Pain when Speaking

Causes and Risk Factors

The American Thoracic Society suggests that Ramipril (ACE inhibitor) is the most likely cause of chronic hoarseness and cough, as this side effect occurs in up to 16% of patients and often begins only after several months of treatment 2, 3
The American College of Chest Physicians recommends that Bisoprolol (beta-blocker) can rarely cause cough and exacerbate symptoms 4, 5
The American Academy of Otolaryngology-Head and Neck Surgery states that laryngopharyngeal reflux (silent reflux) is a common accompanying cause, especially in older, overweight patients with diabetes 7, 8, 9

The European Respiratory Society suggests a trial withdrawal of Ramipril under medical supervision, with monitoring of blood pressure and kidney function during the switch 4, 10
The American Academy of Otolaryngology-Head and Neck Surgery recommends an ear, nose, and throat (ENT) examination with laryngoscopy to assess the vocal cords for inflammation, polyps, or nodules 7, 8, 2
Reflux diagnosis is important, especially if symptoms occur after eating or speaking 1, 2

The American Heart Association suggests switching from Ramipril to an AT1 blocker (e.g., Candesartan) as the first choice, as AT1 blockers do not cause cough 2, 3
The American Academy of Otolaryngology-Head and Neck Surgery recommends a 4-week trial of proton pump inhibitor (PPI) therapy (e.g., Pantoprazol) for suspected reflux 7, 8, 9

The American College of Chest Physicians recommends monitoring symptoms after switching from Ramipril to an AT1 blocker for at least 4 weeks 2, 3
The American Academy of Otolaryngology-Head and Neck Surgery suggests a follow-up ENT examination after 6-8 weeks if symptoms persist 7, 8
Warning signs for immediate medical evaluation include persistent hoarseness despite therapy change for over 8 weeks 7, hemoptysis or weight loss 10, palpable lymph nodes in the neck 10, or increasing dyspnea or swallowing difficulties 5